This case report documents a rare instance of fatal disseminated infection, including myocarditis and pneumonitis, caused by vaccine poliovirus type 2 acquired via household exposure in an infant receiving topical corticosteroids.
Answers are grounded in this paper and cite their sources.
May inform household polio vaccine counseling for corticosteroid-treated infants; leaves open need for prospective safety data.
Sir.—Central nervous system disease secondary to vaccine poliovirus infection is a well-documented phenomenon both in immunocompromised children and in the normal host.¹,²Myocarditis and pneumonitis have not been previously reported as a consequence of vaccinelike strains, to our knowledge, and a diffuse encephalomyelitis is rare. We herein describe a 5-month-old infant who developed multiple organ dysfunction secondary to infection by vaccine poliovirus type 2 acquired by household exposure. Report of a Case.—A 5-month-old male infant presented with failure to thrive and respiratory distress after receiving a regimen of nasal betamethasone dipropionate, 1 mg/d, for three months, which had been prescribed by a local physician for nasal congestion. Recurrent bilateral otitis media, oral thrush, and a monilial rash had become persistent problems. A temperature of 40.6°C accompanied by marked respiratory distress necessitated admission to our hospital. Significant history included the fact that two family members, both children, had
No takes yet. Share an insight, caveat, or question.
ORALIA WELLS (1986) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: